V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158636 | 20060779 | 1.59 | 63.6 | Palliative (P) | 2018-09-26 | 2018-10-01 | ECX | N | N | ECX | 100278944 |
| 20158637 | 20060780 | 1.82 | 74.2 | Palliative (P) | 2019-04-28 | 2019-05-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100952991 |
| 20158642 | 20060781 | 1.6 | 75.8 | Palliative (P) | 2018-12-05 | 2018-12-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100812061 |
| 20158645 | 20060782 | null | 67 | Palliative (P) | 2018-12-24 | 2019-01-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101402860 |
| 20158646 | 20060783 | 1.5 | 67.6 | Adjuvant (A) | 2017-07-31 | 2017-08-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101485879 |
| 20158648 | 20060784 | 1.72 | 48.1 | null | 2016-12-14 | 2016-12-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101246020 |
| 20158649 | 20060785 | 1.58 | 68.9 | Palliative (P) | 2016-02-19 | 2016-02-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100808251 |
| 20158653 | 20060786 | 1.53 | 76.5 | Palliative (P) | null | 2019-03-17 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100657686 |
| 20158654 | 20060787 | 1.73 | 66.1 | Palliative (P) | 2019-12-27 | 2020-01-10 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101859686 |
| 20158655 | 20060788 | 1.71 | 79.4 | null | 2020-03-12 | 2020-03-24 | ECX | 2 | N | ECX | 101619158 |
| 20158658 | 20060789 | 1.67 | 64 | Curative (C) | 2018-06-22 | 2018-07-11 | ECX | 2 | N | ECX | 101416577 |
| 20158663 | 20060790 | 1.54 | 51.9 | Palliative (P) | 2016-11-02 | 2016-11-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100205968 |
| 20158664 | 20060791 | 1.71 | 94.9 | Curative (C) | 2018-11-18 | 2018-11-19 | ECX | 2 | N | ECX | 101238041 |
| 20158665 | 20060792 | 1.68 | 71.6 | Curative (C) | 2018-10-07 | 2018-10-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100961836 |
| 20158666 | 20060793 | 1.75 | 91.3 | Neo-adjuvant (N) | 2019-08-27 | 2019-09-04 | ECX | N | N | ECX | 101080587 |
| 20158667 | 20060794 | 1.76 | 94 | Neo-adjuvant (N) | 2017-08-25 | 2017-08-30 | ECX | 02 | N | ECX | 101693201 |
| 20158671 | 20060795 | 1.7 | 84.5 | Neo-adjuvant (N) | 2019-12-01 | 2019-12-06 | ECX | N | N | ECX | 100804805 |
| 20158672 | 20060796 | 1.58 | 51.2 | Curative (C) | 2019-12-02 | 2019-12-18 | ECX | 02 | N | ECX | 100840821 |
| 20158675 | 20060797 | 1.78 | 67.35 | Palliative (P) | 2017-05-10 | 2017-05-10 | ECX | 02 | N | ECX | 100043904 |
| 20158676 | 20060798 | 1.72 | 71.4 | Adjuvant (A) | 2017-02-26 | 2017-02-26 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101141781 |
| 20158677 | 20060799 | 1.66 | 54.2 | Neo-adjuvant (N) | 2017-08-17 | 2017-08-22 | ECX | N | N | ECX | 100549473 |
| 20158678 | 20060800 | 1.76 | 66.4 | Neo-adjuvant (N) | 2017-12-21 | 2018-01-04 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100532092 |
| 20158679 | 20060801 | 1.63 | 68.1 | Curative (C) | 2017-09-28 | 2017-10-11 | ECX | 02 | null | ECX | 101222727 |
| 20158680 | 20060802 | null | 59.75 | Adjuvant (A) | 2017-09-29 | 2017-10-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100128066 |
| 20158682 | 20060803 | 1.6 | 77 | Neo-adjuvant (N) | 2016-11-07 | 2016-11-10 | ECX | N | N | ECX | 100819744 |
| 20158684 | 20060804 | 1.58 | 110 | Neo-adjuvant (N) | 2016-04-29 | 2016-05-06 | ECX | 02 | N | ECX | 101197302 |
| 20158685 | 20060805 | 1.74 | 60 | Palliative (P) | 2018-07-18 | 2018-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100948646 |
| 20158690 | 20060806 | 1.81 | 71 | Palliative (P) | 2018-06-17 | 2018-06-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101526127 |
| 20158691 | 20060807 | 1.58 | 70.25 | Neo-adjuvant (N) | 2017-04-29 | 2017-05-06 | ECX | 02 | null | ECX | 100768911 |
| 20158692 | 20060808 | 1.8 | 106.5 | Neo-adjuvant (N) | 2018-04-15 | 2018-05-10 | ECX | N | N | ECX | 101461169 |
| 20158694 | 20060809 | 1.73 | 92.8 | Neo-adjuvant (N) | 2019-03-16 | 2019-03-27 | ECX | N | N | ECX | 101752982 |
| 20158696 | 20060810 | 1.53 | 70.4 | Neo-adjuvant (N) | 2020-06-24 | 2020-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100817131 |
| 20158699 | 20060811 | 1.59 | 57.4 | Neo-adjuvant (N) | 2019-04-28 | 2019-05-12 | ECX | 02 | N | ECX | 100165522 |
| 20158700 | 20060812 | 1.56 | 51.8 | Adjuvant (A) | 2018-09-28 | 2018-09-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101814198 |
| 20158701 | 20060813 | null | null | Neo-adjuvant (N) | 2017-04-21 | 2017-04-23 | ECX | N | N | ECX | 100013857 |
| 20158703 | 20060814 | 1.79 | 82.2 | Palliative (P) | 2019-08-16 | 2019-08-18 | ECX | 2 | null | ECX | 101448042 |
| 20158704 | 20060815 | 1.67 | 74.8 | Adjuvant (A) | 2016-08-22 | 2016-09-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100268120 |
| 20158705 | 20060816 | 1.66 | 73 | Neo-adjuvant (N) | 2020-02-02 | 2020-02-04 | ECX | 02 | N | ECX | 100261318 |
| 20158707 | 20060817 | null | 60.3 | Neo-adjuvant (N) | 2016-05-21 | 2016-06-02 | ECX | 02 | null | ECX | 100076890 |
| 20158708 | 20060818 | 1.69 | 60 | Neo-adjuvant (N) | 2018-05-07 | 2018-05-27 | ECX | N | N | ECX | 101588217 |
| 20158712 | 20060819 | 1.8 | 78.3 | Palliative (P) | 2016-04-02 | 2016-04-07 | ECX | N | Y | ECX | 100192958 |
| 20158719 | 20060820 | 1.55 | 76.35 | Neo-adjuvant (N) | 2019-08-25 | 2019-08-26 | ECX | 02 | N | ECX | 101409242 |
| 20158720 | 20060821 | 1.64 | 67.95 | Palliative (P) | 2018-03-11 | 2018-03-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100173218 |
| 20158721 | 20060822 | 1.6 | 91.8 | Palliative (P) | 2018-10-21 | 2018-10-28 | ECX | 02 | N | ECX | 101008702 |
| 20158723 | 20060823 | 1.54 | 94 | Palliative (P) | 2016-02-04 | 2016-02-04 | ECX | N | N | ECX | 101094785 |
| 20158726 | 20060824 | 1.84 | 76.6 | Palliative (P) | 2018-07-22 | 2018-08-10 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100042259 |
| 20158728 | 20060825 | 1.66 | 82.85 | Adjuvant (A) | 2018-11-17 | 2018-11-27 | ECX | 2 | N | ECX | 100914050 |
| 20158729 | 20060826 | 1.83 | 85.3 | Curative (C) | 2019-03-06 | 2019-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100961154 |
| 20158730 | 20060827 | 1.6 | 59 | Palliative (P) | 2020-01-18 | 2020-01-29 | ECX | 02 | N | ECX | 100786952 |
| 20158731 | 20060828 | 1.72 | 77 | Adjuvant (A) | null | 2017-02-04 | ECX | null | N | ECX | 101496102 |